InsidersTradesSigma
Follow the Adlai Nortye Ltd. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €922.8m. The latest transaction was disclosed on 10 June 2026 (J). Among the most active insiders: Ji Ping. All data is accessible without an account.
Analysts rate Adlai Nortye Ltd. Strong Buy (bullish), based on 5 analysts. Average price target: US$28.60.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Adlai Nortye Ltd. is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on NASDAQ under the ticker symbol ADLN.